Host immune response in B-cell lymphomas: friend or foe?
- PMID: 18726146
- DOI: 10.1007/s00005-008-0028-z
Host immune response in B-cell lymphomas: friend or foe?
Abstract
The interaction of B-cell malignancies with the host immune system is a dynamic and bilateral process. Certain lymphomas more commonly arise within a background of autoimmunity or chronic infection. Initiation of these tumors is commonly reliant on antigenic stimulation and/or T-cell help. Apart from its tumor-fueling role, the host immune response plays a critical role in cancer immunosurveillance and immunoediting. The concept of immunoediting holds that the immune system sculpts the tumor's immunogenicity in a dynamic process that involves three essential phases: elimination, equilibrium, and escape. Data obtained by studying gene-targeted animals and human lymphomas that support the critical role of the immune response in the initiation, progression, and immunoediting of lymphoid malignancies are summarized here. A thorough understanding of this interaction will lead to the identification of more rational treatment targets and improved immunotherapies in B-cell lymphomas.
Similar articles
-
Eradication of established B-cell lymphoma by CD19-specific murine T cells is dependent on host lymphopenic environment and can be mediated by CD4+ and CD8+ T cells.J Immunother. 2009 Apr;32(3):207-18. doi: 10.1097/CJI.0b013e318194a921. J Immunother. 2009. PMID: 19242379
-
The immune system--is it relevant to cancer development, progression and treatment?Clin Oncol (R Coll Radiol). 2008 Mar;20(2):101-12. doi: 10.1016/j.clon.2007.10.011. Epub 2007 Nov 26. Clin Oncol (R Coll Radiol). 2008. PMID: 18037277 Review.
-
Immunomodulation and lymphoma in humans.J Immunotoxicol. 2014 Jan-Mar;11(1):1-12. doi: 10.3109/1547691X.2013.798388. Epub 2013 Jun 7. J Immunotoxicol. 2014. PMID: 23746314 Review.
-
Th2-mediated anti-tumour immunity: friend or foe?Tissue Antigens. 2007 Jul;70(1):1-11. doi: 10.1111/j.1399-0039.2007.00869.x. Tissue Antigens. 2007. PMID: 17559575 Review.
-
Cancer immunoediting from immune surveillance to immune escape.Immunology. 2007 May;121(1):1-14. doi: 10.1111/j.1365-2567.2007.02587.x. Epub 2007 Mar 26. Immunology. 2007. PMID: 17386080 Free PMC article. Review.
Cited by
-
Influence of Tumor Location on the Composition of Immune Infiltrate and Its Impact on Patient Survival. Lessons from DCBCL and Animal Models.Front Immunol. 2012 May 4;3:98. doi: 10.3389/fimmu.2012.00098. eCollection 2012. Front Immunol. 2012. PMID: 22566974 Free PMC article.
-
Synchronous hairy cell leukemia and chronic lymphocytic leukemia: a case report with a brief review of literature.Blood Res. 2018 Jun;53(2):160-163. doi: 10.5045/br.2018.53.2.160. Epub 2018 Jun 25. Blood Res. 2018. PMID: 29963523 Free PMC article. No abstract available.
-
Paracoccidioidomycosis in patients with lymphoma and review of published literature.Mycopathologia. 2015 Apr;179(3-4):285-91. doi: 10.1007/s11046-014-9851-4. Epub 2014 Dec 20. Mycopathologia. 2015. PMID: 25526930 Review.
-
Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.Mol Cancer. 2015 Dec 11;14:207. doi: 10.1186/s12943-015-0474-2. Mol Cancer. 2015. PMID: 26654227 Free PMC article. Review.
-
IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/-) monocytes in B-cell non-Hodgkin lymphoma.Blood Cancer J. 2015 Jul 31;5(7):e328. doi: 10.1038/bcj.2015.56. Blood Cancer J. 2015. PMID: 26230952 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
